Moderna, Inc.
Viés de alta

MRNA - Buy after a sell-off, Vaccines are here to stay

Atualizado
Vaccines are here to stay and many companies will have a good balance sheet in coming years. Moderna is a buy and I am DCAing from 186 down to every monthly dip.

MRNA will recover above 200 within 2022
Nota
MRNA is simply bottoming, should be 200+ in a few months.
Nota
Still waiting and expecting a decent rebound above 200.
Nota
Good earnings, and a solid cash flow in MRNA...Ignoring the FUD.

Still MRNA is in business. Looking forward to 200+ finally.
Nota
Pure sideways market - it is here to stay. I loaded more MRNA around 172.x. Can it deliver 225 this year? That should what we ask, instead SIG *Stay-in the Game*
Trend Analysis

Também em:

Aviso legal